Sibylle Lob

Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii

Sibylle Lob, Daryl J. Hoban, Daniel F. Sahm et al. · International Journal of Antimicrobial Agents · 2016 · 165 citations

Life Sciences, Infectious Diseases, Microbiology +16

Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014

Sibylle Lob, Lindsay E. Nicolle, Daryl J. Hoban et al. · Diagnostic Microbiology and Infectious Disease · 2016 · 139 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

<i>In Vitro</i> Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)

Sibylle Lob, Meredith Hackel, Krystyna M. Kazmierczak et al. · Antimicrobial Agents and Chemotherapy · 2017 · 137 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 2013

Sibylle Lob, Krystyna M. Kazmierczak, Robert E. Badal et al. · Antimicrobial Agents and Chemotherapy · 2015 · 107 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

<i>In Vitro</i> Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014

James A. Karlowsky, Sibylle Lob, Krystyna M. Kazmierczak et al. · Journal of Clinical Microbiology · 2017 · 98 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17